- Asbestos exposure and antineutrophil cytoplasmic antibody (ANCA) positivity2003 | Second Faculty of Medicine
- Anti-Saccharomyces Cerevisiae Antibodies (ASCA) and Antineutrophil Cytoplasmic Antibodies(ANCA) in Children and Adolescents with Inflammatory Bowel Diseases2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Asbestos exposure and antineutrophil cytoplasmic antibody (ANCA) positivity2003 | First Faculty of Medicine
- Two familial cases of antineutrophil cytoplasmic antibody (ANCA) - associated vasculitis2006 | First Faculty of Medicine
- Antineutrophil cytoplasmic antibodies (ANCA), their diagnostic importance in children and adults1997 | Second Faculty of Medicine
- Two familial cases of antineutrophil cytoplasmic antibody (ANCA) - associated vasculitis2006 | Faculty of Physical Education and Sport
- Antineutrophil Cytoplasmic Antibodies (ANCA), their Diagnostic Importance in Children and Adults.1997 | Faculty of Physical Education and Sport
- Differential cytokine profile in children with cystic fibrosis2005 | Second Faculty of Medicine
- Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis1998 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry2015 | First Faculty of Medicine
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis2017 | First Faculty of Medicine
- Antineutrophil cytoplasmic antibody-positive sera inhibit candidacidal activity of granulocytes1995 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Silica and Asbestos Exposure in ANCA-Associated Vasculitis with Pulmonary Involvement2005 | Second Faculty of Medicine
- Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa2003 | Second Faculty of Medicine
- Late recovery of renal function by rituximab in a patient with Wegener's granulomatosis2013 | Second Faculty of Medicine
- Lung transplantation for cystic fibrosis: immune system and autoimmunity2001 | Second Faculty of Medicine
- Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations2023 | First Faculty of Medicine
- Exposure to Silica and Risk of ANCA-Associated Vasculitis2006 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study2023 | First Faculty of Medicine
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial2015 | First Faculty of Medicine
- Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives2020 | First Faculty of Medicine
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis2016 | First Faculty of Medicine
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases2021 | First Faculty of Medicine
- Antineutrophil cytoplasmic antibodies in children1998 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial2009 | First Faculty of Medicine
- The spectrum of diseases associated with antineutrophil cytoplasmic antibodies1995 | Second Faculty of Medicine
- Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab2015 | First Faculty of Medicine
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial2019 | First Faculty of Medicine
- Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study2021 | First Faculty of Medicine